FET融合蛋白扰乱生理学DNA修复,并为ATR抑制剂治疗创造一个有针对性的机会
Daniel E Gracilla1, Shruti Menon1, Marcus R Breese2
1Memorial Sloan Kettering Cancer Center New York, NY United States.
Cancer research
|March 11, 2026
概括
针对具有遗传突变的癌症中的DNA修复途径提供了新的希望. 这项研究揭示了FET融合基蛋白如何破坏DNA损伤反应,确定ATR是FET重组癌症的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症遗传学 癌症遗传学
背景情况:
- 基因损伤反应 (DDR) 基因的遗传损失创造了可被合成杀伤性利用的脆弱性.
- FET家族蛋白质是DNA双链断裂 (DSB) 的早期反应者.
- FET融合瘤蛋白与各种类型的瘤和白血病有关.
研究的目的:
- 研究FET蛋白和FET融合基蛋白在DNA修复中的作用.
- 用Ewing肉瘤作为模型,识别FET重组癌症中的治疗漏洞.
- 探索EWSR1::FLI1蛋白对DNA损伤反应通路的影响.
主要方法:
- 利用Ewing肉瘤作为FET重组癌症的模型.
- 研究了EWSR1::FLI1和其他FET融合基蛋白对DNADSB的招募.
- 评估了对ATM激活和信号的影响.
- 评估了补偿ATR信号轴.
- 在患者衍生异种移植模型中测试ATR抑制剂.
主要成果:
- 将FET融合基蛋白招募到DNADSB中抑制了ATM激活和信号传递.
- 在FET重新排列的癌症中,ATR信号轴成为附带依赖.
- 在多种FET重组癌症的临床前模型中,ATR抑制显示出治疗潜力.
结论:
- 致癌蛋白质可以破坏正常的DNA修复机制.
- 在FET重组的癌症中,ATR信号是一个有前途的治疗标.
- 这些发现为ATR抑制剂在这些癌症中的临床试验提供了临床前基础.
更多相关视频
09:58Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
3.2K
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
10.7K
相关概念视频
Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
Targeted Cancer Therapies
1.7K
1.7K
DNA Damage can Stall the Cell Cycle
10.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
10.3K
DNA Damage Can Stall the Cell Cycle
3.3K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.3K
Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
The Intrinsic Apoptotic Pathway
9.1K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.1K
